Market revenue in 2024 | USD 441.7 million |
Market revenue in 2030 | USD 859.6 million |
Growth rate | 11.7% (CAGR from 2024 to 2030) |
Largest segment | Assay kits |
Fastest growing segment | Reagents |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Reagents, Microplates, Probes & Labels, Instruments & Software, Assay Kits, Cell Lines |
Key market players worldwide | BD, Bio-Rad Laboratories Inc, Corning Inc, Charles River Laboratories International Inc, Danaher Corp, Roche Holding AG, Lonza Group Ltd, Merck KGaA, Thermo Fisher Scientific Inc, Promega |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell-based assays market will help companies and investors design strategic landscapes.
Assay kits was the largest segment with a revenue share of 37.65% in 2024. Horizon Databook has segmented the India cell-based assays market based on reagents, microplates, probes & labels, instruments & software, assay kits, cell lines covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the India cell-based assays market , including forecasts for subscribers. This country databook contains high-level insights into India cell-based assays market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account